Skip to main content Skip to left navigation Skip to footer
Skip Left Navigation

Browse by Topic

Hormone Therapy in Postmenopausal Women, Primary Prevention of Chronic Conditions, December 2017

* Indicates an old grade definition


Recommendations: Primary Prevention of Chronic Conditions for Hormone Therapy in Postmenopausal Women

  • Hormone Therapy in Postmenopausal Women : Preventive Medications --Postmenopausal women
    Grade: D
    Specific Recommendations:

    The USPSTF recommends against the use of combined estrogen and progestin for the primary prevention of chronic conditions in postmenopausal women.

    Frequency of Service:

    No Frequency of Service information currently available.

    Risk Factor Information:

    This recommendation statement applies to an average-risk population. Risk factors for a specific chronic condition or individual characteristics that affect the likelihood of experiencing a specific therapy-associated adverse event may cause a woman’s net balance of benefits and harms to differ from that of the average population.

  • Hormone Therapy in Postmenopausal Women: Preventive Medications -- Postmenopausal women who have had a hysterectomy
    Grade: D
    Specific Recommendations:

    The USPSTF recommends against the use of estrogen alone for the primary prevention of chronic conditions in postmenopausal women who have had a hysterectomy.

    Frequency of Service:

    No Frequency of Service information currently available.

    Risk Factor Information:

    No Risk Factor Information currently available.

Prevention TaskForce

You are now leaving Prevention TaskForce website and going to
This website contains links to other federal and state agencies and private organizations. The United States Prevention Services Taskforce (USPSTF) cannot attest to the accuracy of information provided by these website links. Linking to other sites does not constitute an endorsement by USPSTF of the sponsors or the information and products presented on the sites. You will be subject to the destination site's privacy policy when you leave the Prevention TaskForce website.

Continue Cancel